Article
Biology of post-transplant relapse: actionable features.
Hematology. American Society of Hematology. Education Program - 6 Dec 2024
Orofino Giorgio, Vago Luca
Abstract excerpt
In patients receiving allogeneic hematopoietic cell transplantation to cure acute myeloid leukemia (AML), recurrence of the underlying disease, or relapse, represents a crucial unanswered issue and prominent cause of mortality. Still, over recent years, advancements in omic technologies have allowed us to gain new insights into the dynamic changes occurring in cancer and the host over the course of treatments,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
